Sign In
Buy EHVVF
$0.0009
-0.0001 (-10.00%)
At Close: Jun 03, 2026
Ehave Revolutionizes Patient Medical Records for Psychedelic Mental Health
08:51am, Thursday, 21'st Jan 2021
Medical records platform for psychedelic mental health to be available February 1 as a Plugin to the Ehave Dashboard.
Company intends to focus on opportunities in the psychedelic space in the Caribbean and distribute Global 20/20 shares at a later date. Company intends to focus on opportunities in the psychedelic spa
Ehave along with Siri, Cortana, Dragon Professional, and Alexia will change the future of voice and health technology Ehave along with Siri, Cortana, Dragon Professional, and Alexia will change the fu
Ehave, Inc. names Patrick Gallagher Director of Sales and Customer Acquisition
08:30am, Friday, 08'th Jan 2021
Patrick Gallagher with more than 20 years' experience building sales organizations and developing executive business strategies. Patrick Gallagher with more than 20 years' experience building sales or
MIAMI, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics, announced today the Company has signed a partnership agreement with Cognit
Ehave, Inc. Files to List on the Canadian Stock Exchange and Applies to Upgrade to OTCQB Exchange
08:30am, Monday, 04'th Jan 2021
MIAMI, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics and developer of KetaDASH, a home delivery platform for patients who have b
Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value
08:30am, Monday, 28'th Dec 2020
MIAMI, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics and developer of KetaDASH, a home delivery platform for patients who have b
